ARB fails to prevent AF recurrence
26 April 2009
| by Nicola Garrett
Treatment with the angiotensin receptor blocker valsartan does not reduce the incidence of recurrent atrial fibrillation, findings from the GISSI-AF trial show....
Want to read complete article? Please Sign in or Register.